Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (21-30 of 426) with videos related to

Pageof 43
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 16, 2018
Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazineKaiJun Jin, YaLi Sang, Erik De Clercq, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2005
Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral actionJan Balzarini, Miguel Stevens, Erik De Clercq, et al.
Current Medicinal Chemistry|September 15, 2009
Design strategies of novel NNRTIs to overcome drug resistancePeng Zhan, Xinyong Liu, Zhenyu Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2013
Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline-triazine derivativesRahul P Modh, Erik De Clercq, Christophe Pannecouque, et al.
Chemmedchem|July 13, 2012
An efficient synthesis of a hydroxyethylamine (HEA) isostere and its α-aminophosphonate and phosphoramidate derivatives as potential anti-HIV agentsAsish K Bhattacharya, Kalpeshkumar C Rana, Christophe Pannecouque, et al.
Journal of Medicinal Chemistry|January 24, 2022
Discovery of Novel Pyridine-Dimethyl-Phenyl-DAPY Hybrids by Molecular Fusing of Methyl-Pyrimidine-DAPYs and Difluoro-Pyridinyl-DAPYs: Improving the Druggability toward High Inhibitory Activity, Solubility, Safety, and PKLi Ding, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|March 22, 2020
Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivativesMaria Rosa Buemi, Rosaria Gitto, Laura Ielo, et al.
Journal of Medicinal Chemistry|March 27, 2007
Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsLei Ji, Fen-Er Chen, Erik De Clercq, et al.
Antiviral Research|October 28, 2009
Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycleDirk Daelemans, Jean-Maurice Dumont, Brigitte Rosenwirth, et al.
Molecular Pharmacology|February 25, 2005
A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitorsDirk Daelemans, Christophe Pannecouque, George N Pavlakis, et al.
Pageof 43

Showing results (21-30 of 426) with videos related to

Sort By:
Pageof 43
Bioorganic & Medicinal Chemistry Letters|October 16, 2018
Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazineKaiJun Jin, YaLi Sang, Erik De Clercq, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2005
Pyridine N-oxide derivatives: unusual anti-HIV compounds with multiple mechanisms of antiviral actionJan Balzarini, Miguel Stevens, Erik De Clercq, et al.
Current Medicinal Chemistry|September 15, 2009
Design strategies of novel NNRTIs to overcome drug resistancePeng Zhan, Xinyong Liu, Zhenyu Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 19, 2013
Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline-triazine derivativesRahul P Modh, Erik De Clercq, Christophe Pannecouque, et al.
Chemmedchem|July 13, 2012
An efficient synthesis of a hydroxyethylamine (HEA) isostere and its α-aminophosphonate and phosphoramidate derivatives as potential anti-HIV agentsAsish K Bhattacharya, Kalpeshkumar C Rana, Christophe Pannecouque, et al.
Journal of Medicinal Chemistry|January 24, 2022
Discovery of Novel Pyridine-Dimethyl-Phenyl-DAPY Hybrids by Molecular Fusing of Methyl-Pyrimidine-DAPYs and Difluoro-Pyridinyl-DAPYs: Improving the Druggability toward High Inhibitory Activity, Solubility, Safety, and PKLi Ding, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|March 22, 2020
Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivativesMaria Rosa Buemi, Rosaria Gitto, Laura Ielo, et al.
Journal of Medicinal Chemistry|March 27, 2007
Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsLei Ji, Fen-Er Chen, Erik De Clercq, et al.
Antiviral Research|October 28, 2009
Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycleDirk Daelemans, Jean-Maurice Dumont, Brigitte Rosenwirth, et al.
Molecular Pharmacology|February 25, 2005
A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitorsDirk Daelemans, Christophe Pannecouque, George N Pavlakis, et al.
Pageof 43